Published by Springer-Verlag, In Vitro Diagnostic Industry in China is a specialized English monograph that fills a gap and provides a detailed introduction to the history, current status, outstanding companies and products of China's IVD industry.
As of 30 April 2024, there were 82 Chinese IVD listed companies, of which 61 were listed companies with main IVD business (IVD business accounted for more than 50% of the total business), and 21 were listed companies with IVD-related business.
Roche said recently that the US Food and Drug Administration has approved its Cobas EGFR Mutation Test v2 as a companion diagnostic test with AstraZenecas cancer drug Iressa (gefitinib) for first-line treatment of patients with non-small ce
Bruker said recently it has signed a definitive agreement to acquire a majority interest in infectious disease molecular diagnostics firm Hain Lifescience.According to Bruker, Nehren, Germany-based Hain will add capabilities in tuberculosis
Bio-Rad Laboratories reported after the close of the market recentlythat its second quarter revenues increased 14 percent year over year, driven by growth in both its Life Science and Clinical Diagnostics businesses. For the three months end
Abbott recently said that its Diagnostics business revenues grew 47 percent year over year in the second quarter, driven by sales in its rapid diagnostics business, which reflect results for Alere acquired in October 2017. On an organic bas
Xiamen Spacegen, a provider of oncology molecular diagnostics products and services in China, said recentlythat it hadreceived CE marking for six testing kits. These kits include a human thyroid carcinoma RET gene fusions detection kit, whic
Recently, Agilent Technologies announced that it has completed the acquisition of ULTRA Scientifics business assets, a supplier of chemical standards and certified reference materials. Agilent identifies chemical standards as a key enabling
Illumina said after the close of the market recently that it intends to offer approximately $650 million of convertible senior notes due 2023. Illumina also intends to grant the initial purchasers a 30-day optionto purchase up to an addition
Finnish consumer genetic testing firm Negen has turned to BC Platforms for analysis of raw genomic data for clinical reporting purposes, the companies announced recently. Under terms of the new partnership, BC Platforms will run data collect
NEW YORK (GenomeWeb) Bruker said on Thursday that it has acquired Berlin-based JPK Instruments for an undisclosed amount. JPK provides microscopy instrumentation for biomolecular and cellular imaging, as well as force measurements on single
Illumina reported after the close of the market on Monday that its second quarter 2018 revenues rose by 25 percent year over year. The San Diego-based genomics technology company reported total Q2 revenues of $830 million, compared to $662 m
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.